SAREPTA THERAPEUTICS, INC. Capital Expenditures
SAREPTA THERAPEUTICS, INC. (SRPT) reported Capital Expenditures of $2.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $555.00K, a 98.25% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.08M, a 95.23% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $3.59M, a 90.57% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $22.93M, a 38.45% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $101.97M, a 25.54% decline from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $136.96M, a 79.95% increase from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $76.11M, a 146.91% increase from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $30.82M, a 19.92% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 371 month | Payments to Acquire Property, Plant, and Equipment 374 month | Payments to Acquire Property, Plant, and Equipment 377 month | Payments to Acquire Property, Plant, and Equipment 380 month | Payments to Acquire Property, Plant, and Equipment 383 month | Payments to Acquire Property, Plant, and Equipment 386 month | Payments to Acquire Property, Plant, and Equipment 389 month | Payments to Acquire Property, Plant, and Equipment 392 month | Payments to Acquire Property, Plant, and Equipment 395 month | Payments to Acquire Property, Plant, and Equipment 398 month | Payments to Acquire Property, Plant, and Equipment 401 month | Payments to Acquire Property, Plant, and Equipment 404 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $555.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.64M 10-Q · filed 2026-08-05 | $6.23M derived: sum of 3 quarters · filed 2026-08-05 | $29.16M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2026-03-31 | $2.08M 10-Q · filed 2026-05-06 | $5.67M derived: sum of 2 quarters · filed 2026-05-06 | $28.61M derived: sum of 3 quarters · filed 2026-05-06 | $60.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $26.52M derived: sum of 2 quarters · filed 2026-03-02 | $58.32M derived: sum of 3 quarters · filed 2026-08-05 | $101.97M 10-K · filed 2026-03-02 | ||||||||||||
| 2025-09-30 | $22.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $54.73M derived: sum of 2 quarters · filed 2026-08-05 | $98.38M 10-Q · filed 2025-11-06 | $136.46M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-06-30 | $31.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $75.45M 10-Q · filed 2026-08-05 | $113.53M derived: sum of 3 quarters · filed 2026-08-05 | $150.79M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-03-31 | $43.65M 10-Q · filed 2026-05-06 | $81.73M derived: sum of 2 quarters · filed 2026-05-06 | $119.00M derived: sum of 3 quarters · filed 2026-05-06 | $148.16M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||
| 2024-12-31 | $38.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $75.34M derived: sum of 2 quarters · filed 2026-03-02 | $104.51M derived: sum of 3 quarters · filed 2026-03-02 | $136.96M 10-K · filed 2026-03-02 | ||||||||||||
| 2024-09-30 | $37.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $66.43M derived: sum of 2 quarters · filed 2025-11-06 | $98.87M 10-Q · filed 2025-11-06 | $117.91M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-06-30 | $29.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $61.61M 10-Q · filed 2025-08-06 | $80.65M derived: sum of 3 quarters · filed 2026-03-02 | $110.32M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-03-31 | $32.44M 10-Q · filed 2025-05-06 | $51.48M derived: sum of 2 quarters · filed 2026-03-02 | $81.16M derived: sum of 3 quarters · filed 2026-03-02 | $99.06M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2023-12-31 | $19.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $48.71M derived: sum of 2 quarters · filed 2026-03-02 | $66.62M derived: sum of 3 quarters · filed 2026-03-02 | $76.11M 10-K · filed 2026-03-02 | ||||||||||||
| 2023-09-30 | $29.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $47.58M derived: sum of 2 quarters · filed 2024-11-06 | $57.07M 10-Q · filed 2024-11-06 | $65.03M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2023-06-30 | $17.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $27.39M 10-Q · filed 2024-08-07 | $35.36M derived: sum of 3 quarters · filed 2025-02-28 | $43.59M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2023-03-31 | $9.48M 10-Q · filed 2024-05-01 | $17.45M derived: sum of 2 quarters · filed 2025-02-28 | $25.68M derived: sum of 3 quarters · filed 2025-02-28 | $34.76M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2022-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $16.20M derived: sum of 2 quarters · filed 2025-02-28 | $25.27M derived: sum of 3 quarters · filed 2025-02-28 | $30.82M 10-K · filed 2025-02-28 | ||||||||||||
| 2022-09-30 | $8.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $17.31M derived: sum of 2 quarters · filed 2023-11-01 | $22.86M 10-Q · filed 2023-11-01 | $25.07M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | $9.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $14.63M 10-Q · filed 2023-08-02 | $16.84M derived: sum of 3 quarters · filed 2024-02-28 | $26.08M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | $5.55M 10-Q · filed 2023-05-02 | $7.76M derived: sum of 2 quarters · filed 2024-02-28 | $17.00M derived: sum of 3 quarters · filed 2024-02-28 | $22.89M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $11.45M derived: sum of 2 quarters · filed 2024-02-28 | $17.34M derived: sum of 3 quarters · filed 2024-02-28 | $38.49M 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | $9.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $15.13M derived: sum of 2 quarters · filed 2022-11-02 | $36.28M 10-Q · filed 2022-11-02 | $64.89M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-06-30 | $5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $27.04M 10-Q · filed 2022-08-02 | $55.65M derived: sum of 3 quarters · filed 2023-02-28 | $80.96M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-03-31 | $21.15M 10-Q · filed 2022-05-04 | $49.76M derived: sum of 2 quarters · filed 2023-02-28 | $75.06M derived: sum of 3 quarters · filed 2023-02-28 | $94.23M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2020-12-31 | $28.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $53.91M derived: sum of 2 quarters · filed 2023-02-28 | $73.08M derived: sum of 3 quarters · filed 2023-02-28 | $82.20M 10-K · filed 2023-02-28 | ||||||||||||
| 2020-09-30 | $25.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $44.47M derived: sum of 2 quarters · filed 2021-11-03 | $53.59M 10-Q · filed 2021-11-03 | $70.85M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||
| 2020-06-30 | $19.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $28.29M 10-Q · filed 2021-08-04 | $45.55M derived: sum of 3 quarters · filed 2022-03-01 | $54.98M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||
| 2020-03-31 | $9.12M 10-Q · filed 2021-05-05 | $26.38M derived: sum of 2 quarters · filed 2022-03-01 | $35.81M derived: sum of 3 quarters · filed 2022-03-01 | $52.49M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||
| 2019-12-31 | $17.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $26.69M derived: sum of 2 quarters · filed 2022-03-01 | $43.37M derived: sum of 3 quarters · filed 2022-03-01 | $59.63M 10-K · filed 2022-03-01 | ||||||||||||
| 2019-09-30 | $9.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $26.11M derived: sum of 2 quarters · filed 2020-11-05 | $42.37M 10-Q · filed 2020-11-05 | $62.58M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-06-30 | $16.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $32.95M 10-Q · filed 2020-08-05 | $53.15M derived: sum of 3 quarters · filed 2021-03-01 | $73.24M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-03-31 | $16.26M 10-Q · filed 2020-05-06 | $36.47M derived: sum of 2 quarters · filed 2021-03-01 | $56.56M derived: sum of 3 quarters · filed 2021-03-01 | $65.25M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2018-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $40.29M derived: sum of 2 quarters · filed 2021-03-01 | $48.99M derived: sum of 3 quarters · filed 2021-03-01 | $61.16M 10-K · filed 2021-03-01 | ||||||||||||
| 2018-09-30 | $20.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $28.79M derived: sum of 2 quarters · filed 2019-11-07 | $40.95M 10-Q · filed 2019-11-07 | $44.85M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2018-06-30 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $20.86M 10-Q · filed 2019-08-07 | $24.76M derived: sum of 3 quarters · filed 2020-02-26 | $25.53M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2018-03-31 | $12.17M 10-Q · filed 2019-05-08 | $16.07M derived: sum of 2 quarters · filed 2020-02-26 | $16.83M derived: sum of 3 quarters · filed 2020-02-26 | $19.70M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2017-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $4.66M derived: sum of 2 quarters · filed 2020-02-26 | $7.54M derived: sum of 3 quarters · filed 2020-02-26 | $12.00M 10-K · filed 2020-02-26 | ||||||||||||
| 2017-09-30 | $765.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.64M derived: sum of 2 quarters · filed 2018-10-31 | $8.10M 10-Q · filed 2018-10-31 | $11.02M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $7.34M 10-Q · filed 2018-08-08 | $10.25M derived: sum of 3 quarters · filed 2019-02-28 | $11.09M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-03-31 | $4.46M 10-Q · filed 2018-05-03 | $7.38M derived: sum of 2 quarters · filed 2019-02-28 | $8.22M derived: sum of 3 quarters · filed 2019-02-28 | $8.64M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2016-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.75M derived: sum of 2 quarters · filed 2019-02-28 | $4.17M derived: sum of 3 quarters · filed 2019-02-28 | $5.34M 10-K · filed 2019-02-28 | ||||||||||||
| 2016-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.26M derived: sum of 2 quarters · filed 2017-11-01 | $2.43M 10-Q · filed 2017-11-01 | $3.51M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2016-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.59M 10-Q · filed 2017-08-03 | $2.67M derived: sum of 3 quarters · filed 2018-03-01 | $3.82M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2016-03-31 | $1.17M 10-Q · filed 2017-05-04 | $2.25M derived: sum of 2 quarters · filed 2018-03-01 | $3.40M derived: sum of 3 quarters · filed 2018-03-01 | $4.04M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2015-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.23M derived: sum of 2 quarters · filed 2018-03-01 | $2.87M derived: sum of 3 quarters · filed 2018-03-01 | $3.40M 10-K · filed 2018-03-01 | ||||||||||||
| 2015-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.78M derived: sum of 2 quarters · filed 2016-11-07 | $2.32M 10-Q · filed 2016-11-07 | $5.46M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2015-06-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.17M 10-Q · filed 2016-08-09 | $4.31M derived: sum of 3 quarters · filed 2017-02-28 | $16.77M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2015-03-31 | $532.00K 10-Q · filed 2016-05-05 | $3.67M derived: sum of 2 quarters · filed 2017-02-28 | $16.14M derived: sum of 3 quarters · filed 2017-02-28 | $20.65M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2014-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $15.60M derived: sum of 2 quarters · filed 2017-02-28 | $20.12M derived: sum of 3 quarters · filed 2017-02-28 | $25.44M 10-K · filed 2017-02-28 | ||||||||||||
| 2014-09-30 | $12.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $16.98M derived: sum of 2 quarters · filed 2015-11-05 | $22.30M 10-Q · filed 2015-11-05 | $22.91M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||||
| 2014-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $9.84M 10-Q · filed 2015-08-06 | $10.45M derived: sum of 3 quarters · filed 2016-02-25 | $11.78M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||||
| 2014-03-31 | $5.33M 10-Q · filed 2015-05-07 | $5.93M derived: sum of 2 quarters · filed 2016-02-25 | $7.26M derived: sum of 3 quarters · filed 2016-02-25 | $7.69M derived: sum of 4 quarters · filed 2016-02-25 | $27.68M 10-Q · filed 2014-05-08 | |||||||||||
| 2013-12-31 | $608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.94M derived: sum of 2 quarters · filed 2016-02-25 | $2.36M derived: sum of 3 quarters · filed 2016-02-25 | $2.37M 10-K · filed 2016-02-25 | $22.36M 10-K · filed 2014-03-03 | |||||||||||
| 2013-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.75M derived: sum of 2 quarters · filed 2014-11-06 | $1.76M 10-Q · filed 2014-11-06 | $1.76M derived: sum of 4 quarters · filed 2015-02-26 | $21.75M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $435.00K 10-Q · filed 2014-08-07 | $435.00K derived: sum of 3 quarters · filed 2015-02-26 | $400.00K derived: sum of 4 quarters · filed 2015-02-26 | $20.42M 10-Q · filed 2013-08-08 | |||||||||||
| 2013-03-31 | $9.00K 10-Q · filed 2014-05-08 | $9.00K derived: sum of 2 quarters · filed 2015-02-26 | -$26.00K derived: sum of 3 quarters · filed 2015-02-26 | $108.00K derived: sum of 4 quarters · filed 2015-02-26 | $20.00M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$35.00K derived: sum of 2 quarters · filed 2015-02-26 | $99.00K derived: sum of 3 quarters · filed 2015-02-26 | $108.00K 10-K · filed 2015-02-26 | $19.99M 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $99.00K derived: sum of 2 quarters · filed 2013-11-12 | $108.00K 10-Q · filed 2013-11-12 | $313.00K derived: sum of 4 quarters · filed 2014-03-03 | $19.99M 10-Q · filed 2012-11-07 | |||||||||||
| 2012-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $143.00K 10-Q · filed 2013-08-08 | $348.00K derived: sum of 3 quarters · filed 2014-03-03 | $645.00K derived: sum of 4 quarters · filed 2014-03-03 | $20.02M 10-Q · filed 2012-08-07 | |||||||||||
| 2012-03-31 | $9.00K 10-Q · filed 2013-05-09 | $214.00K derived: sum of 2 quarters · filed 2014-03-03 | $511.00K derived: sum of 3 quarters · filed 2014-03-03 | $960.00K derived: sum of 4 quarters · filed 2014-03-03 | $19.89M 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $502.00K derived: sum of 2 quarters · filed 2014-03-03 | $951.00K derived: sum of 3 quarters · filed 2014-03-03 | $1.18M 10-K · filed 2014-03-03 | $19.88M 10-K · filed 2012-03-13 | |||||||||||
| 2011-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $746.00K derived: sum of 2 quarters · filed 2012-11-07 | $973.00K 10-Q · filed 2012-11-07 | $1.18M derived: sum of 4 quarters · filed 2013-03-15 | $19.67M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $676.00K 10-Q · filed 2012-08-07 | $880.00K derived: sum of 3 quarters · filed 2013-03-15 | $1.17M derived: sum of 4 quarters · filed 2013-03-15 | $19.38M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | $227.00K 10-Q · filed 2012-05-10 | $431.00K derived: sum of 2 quarters · filed 2013-03-15 | $719.00K derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||||
| 2010-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $492.00K derived: sum of 2 quarters · filed 2013-03-15 | $832.00K 10-K · filed 2013-03-15 | |||||||||||||
| 2010-09-30 | $288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $628.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2010-06-30 | $340.00K 10-Q · filed 2011-08-08 | |||||||||||||||
| 2009-12-31 | $931.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |